ACTA ENDOCRINOLOGICA (BUC)

The International Journal of Romanian Society of Endocrinology / Registered in 1938

in Web of Science Master Journal List

Acta Endocrinologica(Bucharest) is live in PubMed Central

Journal Impact Factor - click here.

Year Volume Issue First page
10.4183/aeb.
Author
Title
Abstract/Title
From through

  • General Endocrinology

    Gurban C, Zosin I, Sfrijan F, Cojocaru M, Vermesan H, Vermesan D, Savescu I, Radulov I, Drugarin D, Erdelean V

    The OPG/sRANKL system and the low bone mineral density in postmenopausal osteoporosis

    Acta Endo (Buc) 2009 5(1): 27-40 doi: 10.4183/aeb.2009.27

    Abstract
    Background. sRANKL (soluble receptor activator of nuclear factor-kB ligand) and OPG (osteoprotegerin) represent a novel cytokine system with pleiotropic effects on bone remodeling.\r\nAim. The aim of this study was to assess the implications of serum levels of sRANKL, OPG and E2 (estradiol) in the process of bone remodeling of postmenopausal women with osteoporosis.\r\nMethods. The study was performed on 74 patients with postmenopausal osteoporosis, divided into two groups of patients according to the duration of estrogenic deprivation, compared with a control group (n= 20 postmenopausal women without osteoporosis). The serum levels of the enunciated markers were measured by ELISA technique.\r\nResults. In the group I (n= 48, bellow 15 yrs of estrogenic deprivation) the serum levels of sRANKL were 67.63?3.55 pg/mL (p<0.002), those of OPG were 42.15?0.55 pg/mL (p<0.002) and the levels of E2 were 28.32?1.78 pg/mL (p<0.004). In the group II (n= 26, over 15 yrs of estrogenic deprivation) the serum levels of sRANKL were 49.26?2.85 pg/mL (p<0.003), those of OPG 27.78?1.04 pg/mL (p<0.003) and the serum levels of E2 were 19.66?1.23 pg/mL (p<0.002). In the control group (n=20), the serum levels of sRANKL were 32.48?3.03 pg/mL, those of OPG 38.05?4.89 pg/mL and the serum levels of E2 were 43.07?4.04 pg/mL.\r\nConclusions. The serum levels of sRANKL are significantly higher in postmenopausal women with osteoporosis versus postmenopausal women without osteoporosis, attesting osteoclasts activation. The serum levels of OPG in postmenopausal women with osteoporosis were increased in group I, suggesting the osteoblastic activation and decreased in group II, probably secondary to the stimulation of osteoblastic apoptosis.
  • General Endocrinology

    Gurban C, Zosin I, Gotia S, Sfrijan F, Gotia L, Radulov I, Savescu I, Drugarin D

    Correlations between the markers of bone remodeling and bone mineral density in postmenopausal osteoporosis

    Acta Endo (Buc) 2010 6(1): 27-34 doi: 10.4183/aeb.2010.27

    Abstract
    Aim. To assess the levels of s BGP and BAP and correlate them with the rate of bone remodelling.\r\nPatients and Methods. The study was performed on 74 cases with postmenopausal osteoporosis, divided into two groups, according to the duration of estrogenic deprivation, compared with a control group (n= 20, postmenopausal women without osteoporosis). The serum levels of the discussed markers were measured by ELISA technique. BMD was measured using the DXA technique with the assessment of T score.\r\nResults. In the group I: BGP were 20.12?0.87ng/mL (p<0.03), those of BAP 13.76?0.6&#956;g/mL (p<0.001) and sT spine were -3.63?0.65DS (p<0.001). In the group II: BGP were 15.12?1.55ng/mL (p<0.05), those of BAP 11.88?0.38&#956;g/mL (p<0.001) and sT spine were -3.78?0.36DS (p<0.001). The control group presented: BGP of 16.22?1.62ng/mL, those of BAP of 8.68?0.44&#956;g/mL and sT spine of -1.78?0.11DS. The serum levels of BGP in postmenopausal osteoporosis cases were increased in group I (suggesting an osteoblastic activation) and decreased in group II (probably secondary to the stimulation of osteoblastic apoptosis). The serum levels of BAP are significantly increased\r\nin postmenopausal osteoporosis versus control group, attesting osteoblastic activation.\r\nConclusion. Bone resorption begins gradually to outrun a new bone formation rhythm associated with low BMD.
  • Endocrine Care

    Simescu M, Dumitriu L, Sava M, Ciovernache D, Colda A, Balmes E, Ursu H, Bistriceanu M, Zosin I, Duncea I, Balasz J, Kun I, Dragatoiu G, Hazi G, Coamesu I, Harsan T, Stamoran L, Florescu E, Vitiuc M, Varciu M, Budura I, Fugaciu A, Hutanu T, Lepadatu D, Sulac H, Sirbu A

    Urinary Iodine Levels in Schoolchildren and Pregnant Women After the Legislative Changes in the Salt Iodization

    Acta Endo (Buc) 2006 2(1): 33-44 doi: 10.4183/aeb.2006.33

    Abstract
    Endemic goiter occurred in different degrees throughout 2/3 of Romania, mainly in the Carpathian area. The prophylaxis of iodine deficiency disorders (IDD) using salt iodization was introduced in 1956 with potassium iodate, KIO3, 15-25 mg/1kg salt, but only in 23 districts. In 2002 a new legislation introduced the mandatory use of the iodized salt in a higher concentration in households of all 41 districts and also in the baking industry. The study aims to evaluate the effects of iodine legislation changes upon the urinary iodine excretion (UIC) in schoolchildren (study group A) and pregnant women (study group B). Urine samples were collected from 3737 schoolchildren aged 6-14 years of 14 districts and from 1283 pregnant women of 11 districts in the years 2004-2005. In two areas - Bistrita Nasaud and Bucharest - the number of schoolchildren was larger, i.e. 465 and 1617 respectively. UIC was determined in spot urine samples by Sandell Kolthoff?s method. The results show in schoolchildren an increase of the median UIC in 9 out of 14 districts up to 90 ? 61.1 ?g/L (range 12.5-300 ?g/L). Six of these districts are in the Carpathian area. However, in pregnant women in 2004, UIC still showed low levels of 55 ? 48.78 ?g/L (range 12.5-280 ?g/L) in all 11 studied districts and in Bucharest, close to the UIC obtained in the year 2001. In conclusion, this study revealed an increase of median values of UIC in schoolchildren after universal salt iodization program. The persistence of iodine deficiency in pregnant women in the studied districts is an emergency problem that has to be solved as soon as possible. This fact involves the necessity of a large monitoring program in the next years, in all districts in urban and rural areas and in all known pockets of endemia.
  • Endocrine Care

    Haghpanah S, Pishdad P, Zarei T, Shahsavani A, Amirmoezi F, Ilkhanipoor H, Safaei S, Setoodegan F, De Sanctis V, Karimi M

    Frequency of Thyroid Nodules in Patients with ?-Thalassemias in Southern Iran

    Acta Endo (Buc) 2020 16(1): 68-73 doi: 10.4183/aeb.2020.68

    Abstract
    Background. Although thyroid nodules are a common finding in the general population, determining the clinically important nodules is essential. We investigated thyroid nodules or cysts by thyroid ultrasonography (US) in patients with β-thalassemia major (β-TM) and intermedia (β- TI). We also report a β-TI patient who was diagnosed with thyroid cancer six months before our screening. Methods. In this cross-sectional study, 178 patients with β-thalassemias referred to the Thalassemia Clinic in a tertiary hospital affiliated to Shiraz University of Medical Sciences were investigated, from January to June 2016, by US. Results. Thyroid nodules or cysts were detected in 11 patients [total: 6.17 %; 8 patients with β-TM (8.2%) and 3 patients with β-TI (3.7%)]. All nodules were < 1 cm in diameter and were not suspicious of malignancy. All patients, after 1 year of thyroid US follow-up, did not show any significant change in favor of malignancy. Conclusion. Based on our results, the frequency of thyroid nodules was similar to what was reported in the general population. However, a long-term follow-up of these patients is recommended because of the potential carcinogenic effects of iron and hepatitis C infection (HCV). To achieve more precise information, collaborative multicenter studies should be considered.
  • Images in Endocrinology

    Kavecan II, Obrenovic MR, Privrodski BK, Savic RN

    Late Infantile Type of Metachromatic Leukodystrophy Caused by Novel Combination of Heterozygous Arsa Mutations

    Acta Endo (Buc) 2018 14(1): 131-131 doi: 10.4183/aeb.2018.131

  • Endocrine Care

    Toma A, Sava M, Delia C, Simescu M, Tomescu E, Coculescu M

    Universal salt iodization effects on endemic goiter in Arges county, Romania

    Acta Endo (Buc) 2005 1(2): 167-180 doi: 10.4183/aeb.2005.167

    Abstract References
    Background. In the Carpathian area of Romania the Iodine Deficiency Disorders (IDD) including endemic goiter are a public health problem. Recently, the legislation imposing salt iodization was strengthened (from 10 to 20 ± 5 mg iodine/kg salt) and enlarged (universal salt iodization, USI, has been applied to bread industry since 2002). Objective. The effect of bread iodization by law upon the characteristics of goiter endemy was assessed in Arges county, Romania. Design. The characteristics of goiter endemy (as defined by WHO/ICCIDD/UNICEF) were determined in children in the years 1999 (control group C) and 2004 (study group S), two years after universal bread iodization. In the control group C there were 1,241 schoolchildren 6-14 years old, living in 5 villages and in Pitesti town. In the study group S there were 408 schoolchildren 6-12 years old, living in 7 villages and in Pitesti town. After universal bread iodization, a neonatal screening for hypothyroidism was also performed on 11,216 newborns in Arges county, between January 2003 and December 2004. The content of KIO3 in the salt was assessed both in samples collected from village shops in the years 1999 (10 samples) and 2004 (17 samples). The iodine content of drinking water in Arges county villages was assessed in 1999. Methods. Three parameters of IDD endemy were evaluated, i.e. the thyroid volume in schoolchildren by palpation or/and ultrasonography, urinary iodine by the Sandell-Kolthoff method, and neonatal blood TSH levels in dry spot by immunoassay. A questionnaire was filled in by 912 schoolchildren in 1999 and by 408 schoolchildren in 2004.
    1. Hetzel BS. Eliminating iodine deficiency disorders?the role of the International Council in the global partnership. Bull World Health Organ 2002; 80(5):410-413.
    2. Bleichrodt N, Born M. Metaanalysis of research on iodine out its relationshp to cognitive development. The damaged brain of iodine deficiency. Cognizant communication, Ed. Stanbury G.B, 1994:195-200.
    3. Milcu St.M. Endemic Goiter (in Romanian). Bucharest: Editura Academiei Republicii Populare Romane, 1956.
    4. Coculescu M, Ursu H. Endemic goiter and iodine deficiency disorders (in Romanian). In: College of Physicians from Romania. Guidelines for Practical Medicine. Bucharest: InfoMedica, 2001:119-152.
    5. WHO, Unicef, ICCIDD. Assessment of the Iodine Deficiency Disorders and monitoring their elimination. WHO publ.WHO/NHD/01.1, 1-107. 2001. Geneve.
    6. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. [Volumetric analysis of thyroid lobes by realtime ultrasound (author?s transl)]. Dtsch Med Wochenschr 1981; 106(41):1338-1340. [CrossRef]
    7. Bull.World Health Organ. Recommended normative values for thyroid volume in children aged 6-15 years. World Health Organization & International Council for Control of Iodine Deficiency Disorders. Bull World Health Organ 1997; 75(2):95-97.
    8. Zimmermann MB, Saad A, Hess S, Torresani T, Chaouki N. Thyroid ultrasound compared with World Health Organization 1960 and 1994 palpation criteria for determination of goiter prevalence in regions of mild and severe iodine deficiency. Eur J Endocrinol 2 [CrossRef]
    9. Zimmermann MB, Molinari L, Spehl M, Weidinger-Toth J, Podoba J, Hess S et al. Toward a consensus on reference values for thyroid volume in iodine-replete schoolchildren: results of a workshop on interobserver and inter-equipment variation in sonographic [CrossRef]
    10. Pandav CS, Arora NK, Krishnan A, Sankar R, Pandav S, Karmarkar MG. Validation of spot-testing kits to determine iodine content in salt. Bull World Health Organ 2000; 78(8):975-980.
    11. Delange F. Screening for congenital hypothyroidism used as an indicator of the degree of iodine deficiency and of its control. Thyroid 1998; 8(12):1185-1192. [CrossRef]
    12. Toma A, Diaconu B, Sava N, Nedelcu M, Coculescu M. Persistence of neurological endemic cretinism in ancient goitrogenous areas. Acta Endocrinologica (Buc), New Series, in press.
    13. Simescu M, Neagu C, Rusea D, Zosin I, Nicolaescu E, Gudovan E, Marinescu E. Nitrates(N) and organochlorine pesticides(OCP) elimination in subjects with normal and marginal iodine uptake and OCP effects on thyroid parameters. Budapest: P?ter F, Wiersinga
    14. Pretell EA, Delange F, Hostalek U, Corigliano S, Barreda L, Higa AM et al. Iodine nutrition improves in Latin America. Thyroid 2004; 14(8):590-599. [CrossRef]
    15. Golkowski F, Szybinski Z, Huszno B, Stanuch H, Zarnecki A. Ultrasound measurement of thyroid volume in the nation-wide epidemiological survey of iodine deficiency in Poland. Endokrynol Pol 1993; 44(3), 351-358.
    16. Syrenicz A, Napierala K, Celibala R, Majewska U, Krzyzanowska B, Gulinska M et al. Iodized salt consumption, urinary iodine concentration and prevalence of goiter in children from four districts of northwestern Poland (Szczecin coordinating center). End
    17. Grzesiuk W, Kondracka A, Slon M, Wojda M, Nauman J. Salt iodination as an effective method of iodine supplementation. Med Sci Monit 2002; 8(4):CR288-CR291.
    18. Toromanovic A, Tahirovic H. Thyroid volume measurement by ultrasound in schoolchildren from mildly iodine-deficient area. Bosn J Basic Med Sci 2005; 5(1):19-22.
    19. Zamrazil V, Bilek R, Cerovska J, Delange F. The elimination of iodine deficiency in the Czech Republic: the steps toward success. Thyroid 2004; 14(1):49-56. [CrossRef]
    20. Delange F, Van Onderbergen A, Shabana W, Vandemeulebroucke E, Vertongen F, Gnat D et al. Silent iodine prophylaxis in Western Europe only partly corrects iodine deficiency; the case of Belgium. Eur J Endocrinol 2000; 143(2):189-196. [CrossRef]
    21. Aghini-Lombardi F, Antonangeli L, Pinchera A, Leoli F, Rago T, Bartolomei AM et al. Effect of iodized salt on thyroid volume of children living in an area previously characterized by moderate iodine deficiency. J Clin Endocrinol Metab 1997; 82(4):1136-1 [CrossRef]
    22. Vulpoi C, Mogos V, Zbranca E. Thyroid volume in a former iodine deficient area (in Romanian). Romanian Journal of Endocrinology and Metabolism 2002; 1(3):17-21.
    23. Vitti P, Martino E, Aghini-Lombardi F, Rago T, Antonangeli L, Maccherini D et al. Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J Clin Endocrinol Metab 1994; 79(2):600-603. [CrossRef]
    24. Gutekunst R, Martin-Teichert H. Requirements for goiter surveys and the determination of thyroid size. New York: Plenum Press, 1993:109-118.
    25. Zimmermann MB. Assessing iodine status and monitoring progress of iodized salt programs. J Nutr 2004; 134(7):1673-1677.
    26. Zimmermann MB, Hess SY, Adou P, Toresanni T, Wegmuller R, Hurrell RF. Thyroid size and goiter prevalence after introduction of iodized salt: a 5-y prospective study in schoolchildren in Cote d?Ivoire. Am J Clin Nutr 2003; 77(3):663-667.
    27. Jooste PL, Weight MJ, Lombard CJ. Short-term effectiveness of mandatory iodization of table salt, at an elevated iodine concentration, on the iodine and goiter status of schoolchildren with endemic goiter. Am J Clin Nutr 2000; 71(1):75-80.
    28. Zimmermann MB, Wegmuller R, Zeder C, Torresani T, Chaouki N. Rapid relapse of thyroid dysfunction and goiter in school-age children after discontinuation of salt iodization. Am J Clin Nutr 2004; 79(4):642-645.
    29. Costante G, Grasso L, Ludovico O, Marasco MF, Nocera M, Schifino E et al. The statistical analysis of neonatal TSH results from congenital hypothyroidism screening programs provides a useful tool for the characterization of moderate iodine deficiency re
  • Endocrine Care

    Atalay K, Gezer Savur F, Kirgiz A, Erdogan Kaldirim H, Zengi O

    Serum Vitamin D Levels in Different Morphologic Forms of Age Related Cataract

    Acta Endo (Buc) 2020 16(2): 178-182 doi: 10.4183/aeb.2020.178

    Abstract
    Purpose. Vitamin D insufficiency and age related cataract (ARC) are public health problems. We evaluated serum vitamin D levels in ARC patients. Method. A prospective hospital-based crosssectional study was designed to measure the vitamin D status of patients with ARC. Patients have grouped either presence of any type of posterior subcapsular cataract (PSC) (group 1) or ARC without the PSC component (Group 2). After full ophthalmologic consideration, patients over 40 years of age with no history of ocular trauma, multivitamin supplement ingestion, chronic renal failure, thyroidectomy, parathyroidectomy, skin cancer, and cigarette smoking were included in the study. Results. Totally, 79 subjects of which 26 (32.9%) subjects in group 1 and 53 (67.1%) subjects in group 2 were included in the study. Group 1 had mean vitamin D levels of 17.31±13.30 ng/mL. Vitamin D levels in Group 2 were 13.34±7.87 ng/mL. Group 1 did not show vitamin D insufficiency (P = 0.31; one-sample t-test). However, Group 2 showed a statistically significantly lower vitamin D level compared to the insufficiency level of 20ng/mL (P= 0.00; one-sample t-test). Conclusion. Vitamin D may have an important function in lens metabolism. Vitamin D deficiency and cataract development need further extensive researches.
  • Case Report

    Branisteanu DD, Galesanu C, Saviuc E, Lisnic N, Negru D, Bostaca T, Galesanu MR

    One case of sellar and suprasellar chordoma

    Acta Endo (Buc) 2005 1(2): 219-226 doi: 10.4183/aeb.2005.219

    Abstract References
    We describe one case of sellar and suprasellar chordoma found in a 44 year old female, with bitemporal hemianopsia and secondary amenorrhea, submitted to transfrontal surgery and telecobaltotherapy. Chordomas are slow growing neoplasms arising from notochordal remnants of the axial skeleton. The second most common site for chordomas, after the sacrococcygeal region, is the base of the skull. Skull base chordomas commonly result in cranial nerve deficits, such as blurred vision, facial weakness and swallowing difficulty. Occasionally, chordomas localized in the hypothalamic or pituitary region may lead to pituitary stalk disjunction, pituitary insufficiency and diabetes insipidus. Studies show that early diagnosis, combined with aggressive surgical resection, offers the best chance for long-term survival. Although optimal treatment consists of wide excision with adjuvant radiotherapy, skull base chordomas are rarely amenable to complete surgical removal. Traditionally, postoperative irradiation is delivered to doses of 6000-6500 cGy; however this approach controls the chordoma only for a few years. Prognosis depends on the histological grade of the tumor, atypical chordomas showing the lowest survival rate.
    1. Watkins L, Khudados ES, Kaleoglu M, Revesz T, Sacares P, Crockard HA. Skull base chordomas: a review of 38 patients, 1958-88. Br J Neurosurg 1993; 7(3):241-248. [CrossRef]
    2. Schechter MM, Liebeskind AL, Azar-Kia B. Intracranial chordomas. Neuroradiology 1974; 8(2):67-82. [CrossRef]
    3. Haridas A, Ansari S, Afshar F. Chordoma presenting as pseudoprolactinoma. Br J Neurosurg 2003; 17(3):260-262. [CrossRef]
    4. Kakuno Y, Yamada T, Hirano H, Mori H, Narabayashi I. Chordoma in the sella turcica. Neurol Med Chir (Tokyo) 2002; 42(7):305-308. [CrossRef]
    5. Thodou E, Kontogeorgos G, Scheithauer BW, Lekka I, Tzanis S, Mariatos P, Laws ER Jr. Intrasellar chordomas mimicking pituitary adenoma. J Neurosurg 2000; 92(6):976-982. [CrossRef]
    6. Lee HJ, Kalnin AJ, Holodny AI, Schulder M, Grigorian A, Sharer LR. Hemorrhagic chondroid chordoma mimicking pituitary apoplexy. Neuroradiology 1998; 40(11):720-723. [CrossRef]
    7. Kikuchi K, Watanabe K. Huge sellar chordoma: CT demonstration. Comput Med Imaging Graph 1994; 18(5):385-390. [CrossRef]
    8. Pinzer T, Tellkamp H, Schaps P. Intracranial chordoma. Case report of a destructively growing chondroid chordoma in the area of the sella turcica. Zentralbl Neurochir 1993; 54(3):133-138.
    9. Kagawa T, Takamura M, Moritake K, Tsutsumi A, Yamasaki T. A case of sellar chordoma mimicking a non-functioning pituitary adenoma with survival of more than 10 years. Noshuyo Byori 1993; 10(2):103-106.
    10. de Cremoux P, Turpin G, Hamon P, de Gennes JL. Intrasellar chordoma. Sem Hop 1980 18-25; 56(43-44):1769-1773.
    11. Johnsen DE, Woodruff WW, Allen IS, Cera PJ, Funkhouser GR, Coleman LL. MR imaging of the sellar and juxtasellar regions. Radiographics 1991; 11(5):727-758.
    12. Kachhara R, Nair S, Gupta AK, Radhakrishnan VV, Bhattacharya RN. Infrasellar craniopharyngioma mimicking a clival chordoma: a case report. Neurol India 2002; 50(2):198-200.
    13. Wanibuchi M, Uede T, Ishiguro M, Tatewaki K, Kurokawa Y, Yoshida Y. A case of suprasellar intradural chordoma. No Shinkei Geka 1994; 22(3):269-272.
    14. Couldwell WT, Weiss MH, Rabb C, Liu JK, Apfelbaum RI, Fukushima T. Variations on the standard transsphenoidal approach to the sellar region, with emphasis on the extended approaches and parasellar approaches: surgical experience in 105 cases. Neurosurge [CrossRef]
    15. Wang RZ, Ren ZY, Su CB, Yang Y, Tao W, Ma WB, Yin J. Extended transsphenoidal approach to giant tumors in sellar and clival area. Zhonghua Yi Xue Za Zhi 2004; 84(20):1693-1697.
    16. Zhang YZ, Wang CC, Gao XH, Liu PN, He Y, Piao MX. Clinical application of minimally invasive neuroendoscopic techniques. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2005; 27(1):22-25.
    17. Krishnan S, Foote RL, Brown PD, Pollock BE, Link MJ, Garces YI. Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery 2005; 56(4):777-784 [CrossRef]
    18. Radner H, Katenkamp D, Reifenberger G, Deckert M, Pietsch T, Wiestler OD. New developments in the pathology of skull base tumors. Virchows Arch 2001; 438(4):321-335. [CrossRef]
    19. Kakuno Y, Yamada T, Hirano H, Mori H, Narabayashi I. Chordoma in the sella turcica. Neurol Med Chir (Tokyo) 2002; 42(7):305-308. [CrossRef]
    20. Krengli M, Liebsch NJ, Hug EB, Orecchia R. Review of current protocols for protontherapy in USA. Tumori 1998; 84):209-216.
    21. Sims E, Doughty D, Macaulay E, Royle N, Wraith C, Darlison R, Plowman PN. Stereotactically delivered cranial radiation therapy: a ten-year experience of linac-based radiosurgery in the UK. Clin Oncol (R Coll Radiol) 1999; 11(5):303-320. [CrossRef]
  • General Endocrinology

    Basaran R, Onoz M, Bolukbasi FH, Efendioglu M, Sav A

    Low 06-Methylguanine-DNA Methytransferase (MGMT) and Pan-Cytokeratin (PAN-CK) Expression via Immunohistochemistry in Pituitary Adenomas

    Acta Endo (Buc) 2017 13(3): 282-293 doi: 10.4183/aeb.2017.282

    Abstract
    Introduction. Pituitary adenomas (PA) are the third most common intracranial tumors, with an incidence rate of 10-15%. More than half are invasive, infiltrating adjacent structures. The primary objective of this project was to determine whether MGMT expression is associated with the invasiveness of PA. Material and Method. All patients who underwent surgical decompression consecutively between 2007- 2012 were included. All data were obtained from the case records. Formalin-fixed paraffin-embedded (FFPE) tissue specimens were stained with hematoxylin and eosin (HE) and then examined via light microscope. Paraffin blocks that lacked necrosis and hemorrhage were chosen for histologic examination. In addition to an immunoprofile battery that consisted of Ki-67 and p53, MGMT, S-100 and Pan-CK were evaluated as well. Results. The subjects included 25 women and 15 men. The mean age was 48.9 ± 14.5 years. Of these, 63% of cases involved the invasion of adjacent structures. Of the PA, 17 (42%) were non-functioning pituitary adenomas (NFPA). There was a statistically significant relationship between the invasiveness and Ki-67, p53, MGMT expression, and prolactinoma. Gonodotropinomas were mostly non-invasive. FPAs presented invasive features more frequently than NFPAs. Pan-CK was positive in GH-secreting adenomas but negative in FSH- and LH-secreting adenomas. Conclusion. Ki-67 and p53 in lower expression level can be used for evaluating invasiveness but not for recurrence. MGMT expression can be a useful IHC indicator for invasiveness. However, Pan-CK cannot be used for invasiveness or aggressiveness.
  • General Endocrinology

    Basaran R, Gundogan D, Senol M, Bozdogan C, Gezen F, Sav A

    The Expression of Stem Cell Markers (CD133, NESTIN, OCT4, SOX2) in Invasive Pituitary Adenomas

    Acta Endo (Buc) 2020 16(3): 303-310 doi: 10.4183/aeb.2020.303

    Abstract
    Introduction. The pituitary gland serves as the center of the endocrine system. Stem cells are typically found in a specialized microenvironment of the tissue, called the niche, which regulates their maintenance, self-renewal, fate determination, and reaction to external influences. The aim of this study is to elucidate the role of stem cells in the initiation, invasion, and progression of pituitary adenomas. Materials and methods. All specimens were collected between January 2007 and April 2015. Radiological classification (invasiveness) for all cases was performed according to the Wilson-Hardy classification system. Immunohistochemical staining was performed to all specimens for CD133, Oct4, Sox2 and nestin. Results. The study included 48 patients. Of 48 patients, 17 (35.4%) were male and 31 (64.6%) were female. Mean age is 47.10±14.14 (17–86 yrs.). According to the Wilson-Hardy classification system, 27 (56.3%) were noninvasive adenomas. There was no statistical significance between the expression of pituitary stem cell markers (CD133, OCT4, SOX2, nestin) and invasiveness. Conclusion. All stem cell markers are stained extensively in pituitary adenomas, except for SOX2 which was stained weakly. However, there is no effect of stem cells on invasiveness of pituitary adenomas because we cannot find a difference of the staining level between invasive and non-invasive adenomas. Nestin was stained extensively in functional adenomas, especially for GH, PRL, and gonadotropin secreting adenomas. SOX2 was stained extensively for ACTH-secreting adenomas.